These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
683 related articles for article (PubMed ID: 17357281)
1. Tartrate-resistant acid phosphatase 5b and its correlations with other markers of bone metabolism in kidney transplant recipients and dialyzed patients. Małyszko J; Małyszko JS; Pawlak K; Wołczyński S; Myśliwiec M Adv Med Sci; 2006; 51():69-72. PubMed ID: 17357281 [TBL] [Abstract][Full Text] [Related]
2. Correlations of new markers of bone formation and resorption in kidney transplant recipients. Małyszko J; Wołczyński S; Małyszko JS; Konstantynowicz J; Kaczmarski M; Myśliwiec M Transplant Proc; 2003 Jun; 35(4):1351-4. PubMed ID: 12826157 [TBL] [Abstract][Full Text] [Related]
3. [Tartrate-resistant acid phosphatase--TRAP 5b--as a novel marker of bone resorption in patients with irreversible renal failure treated with dialysis]. Nowak Z; Konieczna M; Wańkowicz Z Pol Merkur Lekarski; 2004 Aug; 17(98):138-41. PubMed ID: 15603322 [TBL] [Abstract][Full Text] [Related]
4. Clinical usefulness of serum carboxyterminal propeptide of procollagen I and tartrate-resistant acid phosphatase determinations to evaluate bone turnover in patients with chronic renal failure. López Gavilanes E; González Parra E; de la Piedra C; Caramelo C; Rapado A Miner Electrolyte Metab; 1994; 20(5):259-64. PubMed ID: 7700213 [TBL] [Abstract][Full Text] [Related]
5. Biological markers in the diagnosis of the different forms of renal osteodystrophy. Ferreira A; Drüeke TB Am J Med Sci; 2000 Aug; 320(2):85-9. PubMed ID: 10981481 [TBL] [Abstract][Full Text] [Related]
6. Prediction of bone mass in renal hyperparathyroidism by newly developed bone metabolic markers: evaluation of serum levels of carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen and carboxy-terminal propeptide of type I procollagen. Katagiri M; Fukunaga M; Ohtawa T; Harada T World J Surg; 1996 Sep; 20(7):753-6; discussion 756-7. PubMed ID: 8678946 [TBL] [Abstract][Full Text] [Related]
7. The clinical utility of serum tartrate-resistant acid phosphatase 5b in the assessment of bone resorption in patients on peritoneal dialysis. Yamada S; Tsuruya K; Yoshida H; Taniguchi M; Haruyama N; Tanaka S; Eriguchi M; Nakano T; Kitazono T Clin Endocrinol (Oxf); 2013 Jun; 78(6):844-51. PubMed ID: 23078546 [TBL] [Abstract][Full Text] [Related]
8. Increased bone resorption in HD patients: is it caused by elevated RANKL synthesis? Avbersek-Luznik I; Balon BP; Rus I; Marc J Nephrol Dial Transplant; 2005 Mar; 20(3):566-70. PubMed ID: 15665031 [TBL] [Abstract][Full Text] [Related]
9. Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction. Yamada S; Inaba M; Kurajoh M; Shidara K; Imanishi Y; Ishimura E; Nishizawa Y Clin Endocrinol (Oxf); 2008 Aug; 69(2):189-96. PubMed ID: 18221403 [TBL] [Abstract][Full Text] [Related]
10. [Kidney and bone update : the 5-year history and future of CKD-MBD. Bone metabolic marker in hemodialysis patients update]. Okuno S Clin Calcium; 2012 Jul; 22(7):1009-17. PubMed ID: 22750933 [TBL] [Abstract][Full Text] [Related]
11. [Importance of biochemical indicators of bone turnover in patients on chronic dialysis and after kidney transplantation]. Kusec V; Smalcelj R Acta Med Croatica; 2004; 58(1):51-7. PubMed ID: 15125394 [TBL] [Abstract][Full Text] [Related]
12. Serum cross-linked N-terminal telopeptide of type I collagen for evaluation of renal osteodystrophy in hemodialysis patients. Nakashima A; Yorioka N; Mizutani T; Yamagata Z; Ueno T; Takasugi N Nephron Clin Pract; 2005; 99(3):c78-85. PubMed ID: 15665550 [TBL] [Abstract][Full Text] [Related]
13. Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis. Guañabens N; Parés A; Alvarez L; Martínez de Osaba MJ; Monegal A; Peris P; Ballesta AM; Rodés J J Bone Miner Res; 1998 Apr; 13(4):731-8. PubMed ID: 9580479 [TBL] [Abstract][Full Text] [Related]
14. Relationship between serum sclerostin, bone metabolism markers, and bone mineral density in maintenance hemodialysis patients. Ishimura E; Okuno S; Ichii M; Norimine K; Yamakawa T; Shoji S; Nishizawa Y; Inaba M J Clin Endocrinol Metab; 2014 Nov; 99(11):4315-20. PubMed ID: 25093620 [TBL] [Abstract][Full Text] [Related]
15. Serum crosslaps correlations with serum ICTP and urine DPD in hemodialyzed and peritoneally dialyzed patients. Małyszko J; Wołczyński S; Zbroch E; Brzósko S; Małyszko J; Myśliwiec M Nephron; 2001 Mar; 87(3):283-5. PubMed ID: 11287766 [No Abstract] [Full Text] [Related]
16. Comparison of bone scintigraphy with bone markers in the diagnosis of bone metastasis in lung carcinoma patients. Ebert W; Muley T; Herb KP; Schmidt-Gayk H Anticancer Res; 2004; 24(5B):3193-201. PubMed ID: 15510610 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of serum peptides of collagen synthesis and degradation in dialysis renal osteodystrophy. Mazzaferro S; Pasquali M; Ballanti P; Bonucci E; Costantini S; Chicca S; De Meo S; Perruzza I; Sardella D; Taggi F Nephrol Dial Transplant; 1995; 10(1):52-8. PubMed ID: 7724029 [TBL] [Abstract][Full Text] [Related]
18. Correlation between histomorphometric parameters of bone resorption and serum type 5b tartrate-resistant acid phosphatase in uremic patients on maintenance hemodialysis. Chu P; Chao TY; Lin YF; Janckila AJ; Yam LT Am J Kidney Dis; 2003 May; 41(5):1052-9. PubMed ID: 12722040 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of different bone markers in hemodialyzed patients. Cavalier E; Delanaye P; Collette J; Krzesinski JM; Chapelle JP Clin Chim Acta; 2006 Sep; 371(1-2):107-11. PubMed ID: 16600202 [TBL] [Abstract][Full Text] [Related]